EE508 Cost Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small Cell Lung Cancer in Italy

Abstract

Authors

A. Marcellusi M. Belfiore R. Tempre A. Russo

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×